Need for additional trials of primary prophylaxis in patients with high-risk antiphospholipid antibody profiles: comment on the article by Erkan et al

被引：3
|
作者：
Wahl, Denis [1 ,2 ]
Lecompte, Thomas [1 ,2 ]
Bounameaux, Henri [3 ]
机构：
[1] Nancy Univ Hosp, Vandoeuvre Les Nancy, France
[2] INSERM, U734, F-54511 Vandoeuvre Les Nancy, France
[3] Univ Hosp Geneva, Geneva, Switzerland
来源：
ARTHRITIS AND RHEUMATISM | 2008年 / 58卷 / 02期
关键词：
D O I：
10.1002/art.23160
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：635 / 636
页数：2
相关论文
共 50 条
  • [1] Need for additional trials of primary prophylaxis in patients with high-risk antiphospholipid antibody profiles: comment on the article by Erkan et al - Reply
    Erkan, Doruk
    Lockshin, Michael D.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (02): : 636 - 636
  • [2] Intravenous immunoglobulin and antiphospholipid syndrome: comment on the article by Erkan et al - Reply
    Erkan, D
    Asherson, R
    Cervera, R
    Shoenfeld, Y
    ARTHRITIS AND RHEUMATISM, 2004, 50 (08): : 2711 - 2713
  • [3] Thromboembolic events after fetal loss in patients with antiphospholipid syndrome: comment on the article by Erkan et al
    Tincani, A
    Taglietti, M
    Biasini, C
    Frassi, M
    Gorla, R
    Balestrieri, G
    ARTHRITIS AND RHEUMATISM, 2002, 46 (04): : 1126 - 1127
  • [4] Thromboembolic events after fetal loss in patients with antiphospholipid syndrome: comment on the article by Erkan et al - Reply
    Erkan, D
    Merrill, JT
    Yazici, Y
    Sammaritano, L
    Buyon, JP
    Lockshin, MD
    ARTHRITIS AND RHEUMATISM, 2002, 46 (04): : 1127 - 1127
  • [5] Antiphospholipid antibody profiling: Association with the clinical phenotype of antiphospholipid syndrome? Comment on the article by Otomo et al
    Roggenbuck, Dirk
    Egerer, Karl
    Feist, Eugen
    Burmester, Gerd-Ruediger
    Doerner, Thomas
    ARTHRITIS AND RHEUMATISM, 2012, 64 (08): : 2807 - 2808
  • [6] Antiphospholipid syndrome nephropathy in antiphospholipid antibody-positive patients with systemic lupus erythematosus: comment on the article by Tektonidou et al
    Korkmaz, Cengiz
    ARTHRITIS AND RHEUMATISM, 2005, 52 (03): : 988 - 989
  • [7] Antiphospholipid antibody profiling: association with the clinical phenotype of antiphospholipid syndrome? Comment on the article by Otomo et al Reply
    Otomo, Kotaro
    Atsumi, Tatsuya
    ARTHRITIS AND RHEUMATISM, 2012, 64 (08): : 2808 - 2809
  • [8] Antiphospholipid syndrome nephropathy in antiphospholipid antibody-positive patients with systemic lupus erythematosus: comment on the article by Tektonidou et al Reply
    Tektonidou, Maria G.
    ARTHRITIS AND RHEUMATISM, 2005, 52 (03): : 989 - 990
  • [9] Estimation of SCD primary prophylaxis need in patients with high-risk myocardial infarction treated with primary PCI
    Filipecki, A.
    Wita, K.
    Tabor, Z.
    Orszulak, W.
    Myszor, J.
    Kwasniewski, W.
    Turski, M.
    Urbanczyk-Swic, D.
    Trusz-Gluza, M.
    EUROPEAN HEART JOURNAL, 2009, 30 : 417 - 417
  • [10] Thrombocytopenia in primary antiphospholipid syndrome, a marker of high-risk patients?
    Yelnik, Cecile M.
    Yann Nguyen
    Le Guern, Veronique
    Hachulla, Eric
    Lambert, Marc
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2020, 74 : 106 - 107
12345